Perspectives of Phage Therapy in Non-bacterial Infections
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
While the true value of phage therapy (PT) in human bacterial infections still awaits formal confirmation by clinical trials, new data have been accumulating indicating that in the future PT may be applied in the treatment of non-bacterial infections. Thus, "phage guests" may interact with eukaryotic cells and such interactions with cells of the immune system may protect human health (Guglielmi, 2017) and cause clinically useful immunomodulatory and anti-inflammatory effects when administered for therapeutic purposes (Górski et al., 2017; Van Belleghem et al., 2017). Recently, a vision of how these effects could translate into advances in novel means of therapy in a variety of human pathologies secondary to immune disturbances and allergy was presented (Górski et al., 2018a). In this article we present what is currently known about anti-microbial effects of phage which are not directly related to their antibacterial action and how these findings could be applied in the future in treatment of viral and fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790
Briard, B., Bomme, P., Lechner, B. E., Mislin, G. L. A., Lair, V., Prévost, M.-C., Latgé, J.-P., Haas, H., & Beauvais, A. (2015) · Scientific Reports · doi:10.1038/srep08220 · Cited by 161 · cited 4×
“However, Pa can be inhibitory to Af through the production of multiple antimicrobials such as pyocyanin (5-Nmethyl-1-hydroxyphenazine) (Mangan, 1969; Blyth, 1971; Kerr et al., 1999; Briard et al., 2015), 1-hydroxyphenazine (Mangan, 1969; Kerr et al.”
BackgroundInfluentialBiofilm formation byAspergillus fumigatus
Kaur, S., & Singh, S. (2013) · Medical Mycology · doi:10.3109/13693786.2013.819592 · Cited by 128 · cited 1×
“Pa (Govan and Deretic, 1996; Bjarnsholt et al., 2009; Høiby et al., 2010) and Af (Amin et al., 2010; Baxter et al., 2013; Kaur and Singh, 2014) are among the most common bacterium and fungus infecting airways in CF, respectively.”
BackgroundSass, G., Nazik, H., Penner, J., Shah, H., Ansari, S. R., Clemons, K. V., Groleau, M.-C., Dietl, A.-M., Visca, P., Haas, H., et al. (2018) · Journal of Bacteriology · doi:10.1128/jb.00345-17 · Cited by 128
Cited by
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Considerations for the Use of Phage Therapy in Clinical Practice
Suh, G. A., Lodise, T. P., Tamma, P. D., Knisely, J. M., Alexander, J., Aslam, S., Barton, K. D., Bizzell, E., Totten, K. M. C., Campbell, J. L., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02071-21 · Cited by 378
Vallianou, N., Christodoulatos, G. S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., & Dalamaga, M. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 289
Therapeutic Phages as Modulators of the Immune Response: Practical Implications
Górski, A., Międzybrodzki, R., Jończyk-Matysiak, E., Kniotek, M., & Letkiewicz, S. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad483 · Cited by 41
Self-citationAdvances in the Diagnosis and Management of Invasive Fungal Disease
Formanek, P. E., & Dilling, D. F. (2019) · Chest · doi:10.1016/j.chest.2019.06.032 · Cited by 31
Metadata
- Authors
- Górski, A., Bollyky, P. L., Przybylski, M., Borysowski, J., Międzybrodzki, R., Jończyk-Matysiak, E., & Weber-Dąbrowska, B.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2019-01-09
- Volume
- 9
- Pages
- 3306-3306
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2909133443
- Cited by
- 63
- References
- 5
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.